Pharma channel feed

Pad­lock share­hold­ers sue Bris­tol My­ers over mile­stone dis­pute af­ter 2016 ac­qui­si­tion

5 months ago
Deals
Law

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

5 months ago
R&D

Dur­ing Covid, RFK Jr. lob­bied against vac­cine EUAs for chil­dren. As HHS sec­re­tary, he could re­scind them

5 months ago
FDA+
Coronavirus

Drugs are ap­proved — and made avail­able — faster in US than most of EU, da­ta show

5 months ago
FDA+
Marketing

Can­del’s shares soar on Phase 3 prostate can­cer da­ta de­spite un­clear prospects

5 months ago
R&D

Eli Lil­ly has tapped tele­health start­up Ro to dis­trib­ute its sin­gle-dose Zep­bound vials

5 months ago
Startups
Health Tech

The End­points 100: The biotech in­dus­try braces for Trump 2.0

5 months ago
Deals
Bioregnum

NewAms­ter­dam hits pri­ma­ry end­point in lat­est Phase 3 tri­al of CETP in­hibitor

5 months ago
R&D

UniQure stock dou­bles on FDA 'align­men­t' over ac­cel­er­at­ed ap­proval for Hunt­ing­ton's drug

5 months ago
FDA+

J&J, Leg­end’s Carvyk­ti clears a type of blood can­cer in ‘nine out of 10’ pa­tients

5 months ago

Roche ini­tial­ly did­n't want to buy Po­sei­da — and part­ner Astel­las did­n't sub­mit an of­fer, new fil­ings show

5 months ago
Deals

BTK in­hibitors from As­traZeneca, Eli Lil­ly and BeiGene take cen­ter stage in CLL

5 months ago
R&D

Ar­cel­lx and Gilead seek to un­seat Leg­end and J&J with mul­ti­ple myelo­ma cell ther­a­py

5 months ago
R&D
Cell/Gene Tx

Ret­ro­spec­tive analy­sis shows po­ten­tial for GLP-1s to treat blood clots

5 months ago
R&D

Trump el­e­vates dis­proven link be­tween vac­cines and autism, say­ing ‘some­thing is go­ing on’

5 months ago

Supreme Court de­clines to take PhRMA-Arkansas 340B case

5 months ago
FDA+
Law

Agios' stock drops af­ter dis­clos­ing new liv­er-re­lat­ed safe­ty warn­ing in fil­ing to FDA

5 months ago
FDA+

GSK re­ports Blenrep over­all sur­vival da­ta in mul­ti­ple myelo­ma as it plots mar­ket reen­try

5 months ago
R&D

ICER finds Ver­tex's non-opi­oid pain treat­ment could bring cost sav­ings at a low­er price

5 months ago
R&D

Ab­b­Vie, Gen­mab tout Ep­kin­ly com­bos in ear­li­er lines of non-Hodgkin lym­phoma

5 months ago
R&D

Ab­b­Vie de­clares third Phase 3 Parkin­son’s win from Cerev­el takeover

5 months ago
R&D

Some re­search shows pa­tients don’t stick with GLP-1s for long. Ama­zon Phar­ma­cy and Ro say they're chang­ing that

5 months ago
Startups
Health Tech

In­sur­ance ex­ec­u­tive killing puts spot­light on se­cu­ri­ty mea­sures at JP Mor­gan meet­ing

5 months ago

Af­ter switch­ing reg­u­la­to­ry plans, As­traZeneca and Dai­ichi re­port pooled ADC da­ta in mu­tant lung can­cer

5 months ago
R&D
First page Previous page 21222324252627 Next page Last page
A service from the Financial Times